Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125303851 | 12530385 | 1 | I | 201605 | 20160624 | 20160706 | 20160706 | EXP | GB-MHRA-EYC 00141303 | GB-LUPIN PHARMACEUTICALS INC.-E2B_00005733 | LUPIN | 60.00 | YR | M | Y | 117.00000 | KG | 20160706 | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125303851 | 12530385 | 1 | I | HARVONI | LEDIPASVIRSOFOSBUVIR | 1 | Oral | U | UNKNOWN | 0 | |||||||||
| 125303851 | 12530385 | 2 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | UNKNOWN | 77670 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125303851 | 12530385 | 1 | Chronic hepatitis C |
| 125303851 | 12530385 | 2 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125303851 | 12530385 | CA |
| 125303851 | 12530385 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125303851 | 12530385 | Anxiety | |
| 125303851 | 12530385 | Cold sweat | |
| 125303851 | 12530385 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125303851 | 12530385 | 1 | 201603 | 0 | ||
| 125303851 | 12530385 | 2 | 2014 | 0 |